Olmutinib (HM61713, BI-1482694) is an orally active and irreversible third EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain. Olmutinib is used for NSCLC[1][2].
Molecular Weight:
486.59
Purity:
99.88
CAS Number:
[1353550-13-6]
Formula:
C26H26N6O2S
Target:
EGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
